ClinicalTrials.Veeva

Menu

Effect of Changing Physiological Conditions on Myogenic Oscillations: Pilot Study

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status and phase

Completed
Early Phase 1

Conditions

Vascular Diseases

Treatments

Other: Increased venous pressure
Other: tetanic stimulus
Drug: Calcium Chloride
Drug: Clevidipine
Drug: Dexmedetomidine
Drug: Phenylephrine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Spontaneous myogenic oscillations will be studied under general anesthesia using finger photoplethysmography. This pilot study will explore potential physiological conditions that will effect the amplitude and/or frequency of myogenic oscillations.

Full description

This is a single center, nonrandomized, nonblinded, interventional clinical pilot research study that plans to enroll 40 patients.

Study will be conducted while subjects are under general anesthesia.

Myogenic oscillations will be measured using finger photoplethysmography. Changes in the amplitude and/or frequency of these oscillations will be analyzed in response to the interventions. Arterial blood pressure will be recorded to verify the efficacy of the interventions.

Six different interventions that will either lower or increase blood pressure will be applied to the subjects. Each subject will receive 1 or 2 of the six interventions. Each of the 6 interventions will be applied to 8 subject.

The interventions that the subject will not be randomized. They will be determined by the subjects blood pressure immediately before the intervention to guarantee that the blood pressure manipulations are within a safe range.

Data will be analyzed offline using Matlab.

Enrollment

40 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Over 18 yrs of age
  2. Undergoing surgery in Moffitt-Long operating rooms
  3. Receiving general anesthesia
  4. Will have an intra-arterial catheter for clinical purposes
  5. Able to consent in english

Exclusion criteria

  1. Under 18 years of age
  2. unable to provide informed consent
  3. Pregnancy

Trial design

Primary purpose

Basic Science

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 6 patient groups

Phenylephrine
Experimental group
Description:
Phenylephrine (100 ug/ml) infusion will be used to increase blood pressure by 20 mmHg
Treatment:
Drug: Phenylephrine
Dexmedetomidine
Experimental group
Description:
Dexmedetomidine infusion will be used to increase blood pressure by 20 mmHg
Treatment:
Drug: Dexmedetomidine
Clevidipine
Experimental group
Description:
Clevidipine infusion will be used to increase blood pressure by 20 mmHg
Treatment:
Drug: Clevidipine
Calcium Chloride
Experimental group
Description:
Calcium Chloride will be administered to increase blood pressure and to increase blood calcium concentration
Treatment:
Drug: Calcium Chloride
tetanic stimulus
Experimental group
Description:
A 5 second 70 mA tetanic stimulus will be used to increase peripheral vascular tone
Treatment:
Other: tetanic stimulus
Increased venous pressure
Experimental group
Description:
A 5 minute inflation of a noninvasive blood pressure cuff to 30 mmHg to increase venous pressure in the arm.
Treatment:
Other: Increased venous pressure

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems